Harvest Fund Management Co., LTD Gilead Sciences, Inc. Transaction History
Harvest Fund Management Co., LTD
- $1.66 Billion
- Q3 2024
A detailed history of Harvest Fund Management Co., LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 57,377 shares of GILD stock, worth $5.27 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
57,377
Previous 45,301
26.66%
Holding current value
$5.27 Million
Previous $3.11 Million
54.73%
% of portfolio
0.29%
Previous 0.23%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.6 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.03 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.68 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.53 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $115B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...